Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The history shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a new revision of the record was posted to update the entry.
    Difference
    0.1%
    Check dated 2026-06-06T23:19:54.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.5.3 to v3.5.4. This represents a minor backend update affecting the record-history display.
    Difference
    0.1%
    Check dated 2026-05-16T09:26:37.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The record history reflects a newer submitted version (including a “Study Status” update) and updates the displayed revision label to v3.5.3, replacing an older revision label entry. No concrete change to core study details is visible from the provided change text alone.
    Difference
    0.3%
    Check dated 2026-04-25T05:28:57.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The history now shows a new revision entry v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T03:10:39.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    The record history now includes Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T18:40:11.000Z thumbnail image
  8. Check
    118 days ago
    Change Detected
    Summary
    The page history shows Revision: v3.4.2 in place of v3.4.1 in the footer, indicating a minor site update. This change does not affect study data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T03:54:47.000Z thumbnail image

Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.